Literature DB >> 7927828

In vitro stepwise selection of resistance to quinolones, beta-lactams and amikacin in nosocomial gram-negative bacilli.

M Michéa-Hamzehpour1, A Kahr, J C Pechère.   

Abstract

The ability of six antibiotics to produce resistance by stepwise selection on agar medium was assessed in 24 gram-negative rods. Escherichia coli was the strain least prone to selection of resistance, whereas Pseudomonas aeruginosa frequently developed resistance to all antibiotics. When used alone, ciprofloxacin, pefloxacin, amikacin, ceftazidime and cefpirome were associated with a comparable risk of acquired resistance (in 14 to 17 out of 24 strains); imipenem selected resistant strains in 10/24 isolates (5/18 in non-pseudomonas strains). The number of strains exhibiting cross resistance with structurally unrelated antibiotics was 11 after pefloxacin treatment, eight after exposure to ciprofloxacin, six after ceftazidime, and one after imipenem or cefpirome. The combination of ciprofloxacin with amikacin was less efficient in reducing acquisition of resistance than the combination of ciprofloxacin with a beta-lactam: ciprofloxacin plus cefpirome was especially potent in this respect.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7927828     DOI: 10.1007/bf01793574

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  17 in total

1.  Exploring new strategies to fight drug-resistant microbes.

Authors:  A Gibbons
Journal:  Science       Date:  1992-08-21       Impact factor: 47.728

2.  Outer membrane protein D2 catalyzes facilitated diffusion of carbapenems and penems through the outer membrane of Pseudomonas aeruginosa.

Authors:  J Trias; H Nikaido
Journal:  Antimicrob Agents Chemother       Date:  1990-01       Impact factor: 5.191

3.  Resistance to pefloxacin in Pseudomonas aeruginosa.

Authors:  M Michea-Hamzehpour; C Lucain; J C Pechere
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

4.  Microbial Selection.

Authors:  V Bryson; W Szybalski
Journal:  Science       Date:  1952-07-18       Impact factor: 47.728

5.  Combination therapy: a way to limit emergence of resistance?

Authors:  M Michéa-Hamzehpour; J C Pechère; B Marchou; R Auckenthaler
Journal:  Am J Med       Date:  1986-06-30       Impact factor: 4.965

6.  Restriction maps of the regions coding for methicillin and tobramycin resistances on chromosomal DNA in methicillin-resistant staphylococci.

Authors:  K Ubukata; R Nonoguchi; M Matsuhashi; M D Song; M Konno
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

7.  Resistance to ciprofloxacin appearing during therapy.

Authors:  N X Chin; N Clynes; H C Neu
Journal:  Am J Med       Date:  1989-11-30       Impact factor: 4.965

8.  Widespread quinolone resistance among methicillin-resistant Staphylococcus aureus isolates in a general hospital.

Authors:  I Shalit; S A Berger; A Gorea; H Frimerman
Journal:  Antimicrob Agents Chemother       Date:  1989-04       Impact factor: 5.191

9.  Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors:  C C Sanders; W E Sanders; R V Goering; V Werner
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

10.  The relationship between antecedent antibiotic use and resistance to extended-spectrum cephalosporins in group I beta-lactamase-producing organisms.

Authors:  K L Jacobson; S H Cohen; J F Inciardi; J H King; W E Lippert; T Iglesias; C J VanCouwenberghe
Journal:  Clin Infect Dis       Date:  1995-11       Impact factor: 9.079

View more
  8 in total

1.  Characterization of β-lactamase- and efflux pump-mediated multiple antibiotic resistance in Salmonella Typhimurium.

Authors:  Md Jalal Uddin; Juhee Ahn
Journal:  Food Sci Biotechnol       Date:  2018-01-13       Impact factor: 2.391

Review 2.  Cefpirome. A review of its antibacterial activity, pharmacokinetic properties and clinical efficacy in the treatment of severe nosocomial infections and febrile neutropenia.

Authors:  L R Wiseman; H M Lamb
Journal:  Drugs       Date:  1997-07       Impact factor: 9.546

3.  Differences in 23S ribosomal RNA mutations between wild-type and mutant macrolide-resistant Chlamydia trachomatis isolates.

Authors:  Yong Jiang; Hui Zhu; Li-Na Yang; Yuan-Jun Liu; Shu-Ping Hou; Man-Li Qi; Quan-Zhong Liu
Journal:  Exp Ther Med       Date:  2015-06-24       Impact factor: 2.447

4.  Efflux pump gene hefA of Helicobacter pylori plays an important role in multidrug resistance.

Authors:  Zhi-Qiang Liu; Peng-Yuan Zheng; Ping-Chang Yang
Journal:  World J Gastroenterol       Date:  2008-09-07       Impact factor: 5.742

Review 5.  Ciprofloxacin. An updated review of its pharmacology, therapeutic efficacy and tolerability.

Authors:  R Davis; A Markham; J A Balfour
Journal:  Drugs       Date:  1996-06       Impact factor: 9.546

6.  Development of phage-based assay to differentiate ciprofloxacin resistant and sensitive Salmonella Typhimurium.

Authors:  Nana Nguefang Laure; Juhee Ahn
Journal:  Food Sci Biotechnol       Date:  2021-01-06       Impact factor: 2.391

7.  Evaluation of lytic bacteriophages for control of multidrug-resistant Salmonella Typhimurium.

Authors:  Lae-Seung Jung; Tian Ding; Juhee Ahn
Journal:  Ann Clin Microbiol Antimicrob       Date:  2017-09-22       Impact factor: 3.944

8.  In vitro evaluation of antibiotics' combinations for empirical therapy of suspected methicillin resistant Staphylococcus aureus severe respiratory infections.

Authors:  Lorenzo Drago; Elena De Vecchi; Lucia Nicola; Maria Rita Gismondo
Journal:  BMC Infect Dis       Date:  2007-09-21       Impact factor: 3.090

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.